Sangamo Therapeutics, Inc. (SGMO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Sangamo Therapeutics, Inc. (SGMO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $30.7M, listed on PNK, employing roughly 127 people, carrying a beta of 1.29 to the broader market. Sangamo Therapeutics, Inc. Led by Alexander D. Macrae Ch.B, public since 2000-04-06.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for SGMO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →